HomeTherapeutic areasImmunology › Graves' Disease

Graves' Disease (2 companies)

Companies with an active program in Graves' Disease.

Ticker Company Therapeutic areas Programs Lead stage Programs
IMVT Immunovant ImmunologyNeurology Rare 1 Phase 3 6
VRDN Viridian Therapeutics ImmunologyOphthalmology 1 Approved 5